2 -aminocarbonyl substituted piperazine or diaza-cyclic compounds as apoptosis protein inhibitor (IAP) modulators

Details for Australian Patent Application No. 2006236714 (hide)

Owner Novartis AG

Inventors Taube, Roswitha; Eckl, Robert; Thormann, Michael; Straub, Christopher; Treml, Andreas; Almstetter, Michael; Chen, Zhouliang

Agent Davies Collison Cave

Pub. Number AU-A-2006236714

PCT Pub. Number WO2006/113376

Priority 102005017116.8 13.04.05 DE

Filing date 13 April 2006

Wipo publication date 26 October 2006

International Classifications

C07D 295/18 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

25 October 2007 PCT application entered the National Phase

  PCT publication WO2006/113376 Priority application(s): WO2006/113376

20 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006236715-Corneal mask formed of degradation resistant polymer

2006236711-Novel vaccine formulations